Home/Filings/4/0001714899-24-000219
4//SEC Filing

Schenkein David P 4

Accession 0001714899-24-000219

CIK 0001714899other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 4:18 PM ET

Size

12.5 KB

Accession

0001714899-24-000219

Insider Transaction Report

Form 4
Period: 2024-11-11
Transactions
  • Exercise/Conversion

    Common Stock

    2024-11-11$18.00/sh+47,165$848,97068,661 total
  • Sale

    Common Stock

    2024-11-11$32.09/sh27,129$870,57041,532 total
  • Sale

    Common Stock

    2024-11-11$32.87/sh32,312$1,062,0959,220 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-11-1147,1650 total
    Exercise: $18.00Exp: 2027-12-06Common Stock (47,165 underlying)
Holdings
  • Common Stock

    (indirect: See footnote)
    26,232
  • Common Stock

    (indirect: See footnote)
    31,232
Footnotes (7)
  • [F1]Includes 5,967 Unvested RSUs.
  • [F2]The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted August 12, 2024.
  • [F3]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $31.54 to $32.53 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  • [F4]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $32.54 to $33.28 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  • [F5]The shares are held of record by the David P. Schenkein 2004 Revocable Trust, for which the Reporting Person serves as a trustee.
  • [F6]The shares are held of record by the Amy P. Schenkein 2004 Revocable Trust, for which the Reporting Person's spouse serves as a trustee.
  • [F7]25% of the shares subject to the option shall vest on December 7, 2018 and an additional 1/48 of the shares vest monthly thereafter.

Issuer

Denali Therapeutics Inc.

CIK 0001714899

Entity typeother

Related Parties

1
  • filerCIK 0001578200

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:18 PM ET
Size
12.5 KB